申请人:Societe Cortial, S.A.
公开号:US04497812A1
公开(公告)日:1985-02-05
This invention relates to new 2-amino-5-aminomethyl-2-oxazolines, the method of preparing them, and their pharmacological properties making possible their application in cardiovascular, psychotropic, antiinflammatory antiallergic, antihistamine, antiH.sub.2 therapy. These new products have the general formula: ##STR1## wherein R.sub.1 and R.sub.2 independently represent an alkyl radical of C.sub.1 to C.sub.4, or a carbocyclic alkyl radical having less than 4 rings, or a carbocyclic radical having less than 4 rings; R.sub.1 and R.sub.2 can form, with the nitrogen atom to which they are attached, a 4 to 7 member heterocycle containing 1 or 2 nitrogen atoms, and either 1 or 0 oxygen atoms. This heterocycle can be substituted by R with R being a lower alkyl, allyl, benzyl, pyridyl, phenyl substituted or not by one or more substituents such as halogen, trifluoromethyl, methyl, methoxy, hydroxy.
本发明涉及新的2-氨基-5-氨甲基-2-噁唑烷,其制备方法以及它们的药理特性,使其能够应用于心血管、精神药物、抗炎、抗过敏、抗组胺、抗H.sub.2治疗。这些新产品的一般式为:##STR1## 其中R.sub.1和R.sub.2独立地表示C.sub.1到C.sub.4的烷基基团,或者具有少于4个环的碳环烷基基团,或者具有少于4个环的碳环基团;R.sub.1和R.sub.2可以与它们所连接的氮原子形成4到7个成员的杂环,其中包含1或2个氮原子,以及1或0个氧原子。这种杂环可以由R取代,其中R是低烷基、烯丙基、苯甲基、吡啶基、苯基取代或不取代一个或多个取代基,如卤素、三氟甲基、甲基、甲氧基、羟基。